Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
3.720
+0.040 (1.09%)
Nov 22, 2024, 4:00 PM EST - Market closed
Mereo BioPharma Group Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 576 | 323 | 88 | 174 | 242 | 64 | |
| Market Cap Growth | 292.34% | 269.38% | -49.64% | -28.05% | 276.02% | - | |
| Enterprise Value | 502 | 282 | 17 | 50 | 221 | 60 | |
| Last Close Price | 3.72 | 2.31 | 0.75 | 1.60 | 3.58 | 3.28 | |
| PE Ratio | - | - | - | 13.66 | - | - | |
| PS Ratio | 631.32 | 32.34 | - | 4.77 | - | - | |
| PB Ratio | 7.92 | 6.40 | 1.70 | 1.98 | -16.14 | 1.60 | |
| P/TBV Ratio | 8.80 | 6.54 | 1.70 | 2.74 | - | - | |
| EV/Sales Ratio | 502.38 | 28.17 | - | 1.38 | - | - | |
| Debt / Equity Ratio | 0.09 | 0.12 | 0.30 | 0.19 | -1.20 | 0.81 | |
| Asset Turnover | - | 0.14 | - | 0.39 | - | - | |
| Quick Ratio | 5.83 | 6.38 | 2.89 | 7.66 | 3.23 | 0.94 | |
| Current Ratio | 6.10 | 6.72 | 3.09 | 7.92 | 3.47 | 1.02 | |
| Return on Equity (ROE) | -62.11% | -57.81% | -53.63% | 34.85% | -1294.27% | -95.43% | |
| Return on Assets (ROA) | - | -23.57% | -28.67% | -13.82% | -31.43% | -31.85% | |
| Return on Capital (ROIC) | -28.94% | -27.52% | -34.13% | -24.29% | -62.09% | -38.57% | |
| Earnings Yield | -7.86% | -9.11% | -48.22% | 7.32% | -67.72% | -54.22% | |
| FCF Yield | -5.24% | -6.53% | -55.78% | -3.32% | -11.74% | -71.51% | |
| Buyback Yield / Dilution | -12.61% | -9.33% | -8.63% | -63.82% | -279.04% | -25.69% | |
| Total Shareholder Return | -12.61% | -9.33% | -8.63% | -63.82% | -279.04% | -25.69% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.